Open original FDA record ↗Recall record
- FDA identifier
- Z-0879-2023
- Company in FDA record
- Detect Headquarters
- FDA classification date
- Jan 4, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of supportive treatment and lack of monitoring of infected individuals and their household or other close contacts for symptoms resulting in increased risk of spread of COVID-19 within the community.
Source facts
- Action
- On December 8, 2022, the firm notified affected enterprise/wholesale customers through email with subject line "URGENT: Voluntary Recall of Three Lots of Detect Covid-19 Tests". Direct customers were notified on December 12, 2022. Customers were instructed to locate unused tests from the affected lots and dispose of them. Customers may receive a refund for the recalled tests once they complete an acknowledgement form and return it to Detect.
- Initiated
- 2022-12-08
- Root cause
- Component design/selection
- Distribution
- Domestic distribution nationwide. Foreign distribution to Hong Kong.
- Recall number
- Z-0879-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197413
- FDA classified
- 2023-01-04
- Recall event number
- 91300